LENZ
Price:
$27.9
Market Cap:
$778.71M
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
Industry
Biotechnology
IPO Date
2024-03-22
Stock Exchange
NASDAQ
Ticker
LENZ
According to LENZ Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -25.63%. This represents a change of 297.62% compared to the average of -6.45% of the last 4 quarters.
The mean historical ROE of LENZ Therapeutics, Inc. over the last ten years is 93.01%. The current -25.63% ROE has changed -127.56% with respect to the historical average. Over the past ten years (40 quarters), LENZ's ROE was at its highest in in the December 2020 quarter at 648.33%. The ROE was at its lowest in in the June 2023 quarter at -24.68%.
Average
93.01%
Median
-21.27%
Minimum
-67.90%
Maximum
697.68%
Discovering the peaks and valleys of LENZ Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 14.10%
Maximum Annual ROE = 697.68%
Minimum Annual Increase = -102.60%
Minimum Annual ROE = -67.90%
| Year | ROE | Change |
|---|---|---|
| 2024 | -24.39% | -64.08% |
| 2023 | -67.90% | 99.09% |
| 2022 | -34.11% | 87.90% |
| 2021 | -18.15% | -102.60% |
| 2020 | 697.68% | 14.10% |
The current ROE of LENZ Therapeutics, Inc. (LENZ) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-42.13%
5-year avg
110.63%
10-year avg
93.01%
LENZ Therapeutics, Inc.’s ROE is greater than GH Research PLC (-16.71%), greater than ARS Pharmaceuticals, Inc. (-38.77%), less than Nanobiotix S.A. (155.77%), greater than Maravai LifeSciences Holdings, Inc. (-42.64%), greater than Rezolute, Inc. (-62.82%), greater than Geron Corporation (-30.28%), greater than Tyra Biosciences, Inc. (-31.80%), greater than Savara Inc. (-69.05%), greater than Prime Medicine, Inc. (-163.51%), greater than Arbutus Biopharma Corporation (-50.20%),
| Company | ROE | Market cap |
|---|---|---|
| -16.71% | $952.15M | |
| -38.77% | $978.98M | |
| 155.77% | $1.04B | |
| -42.64% | $1.02B | |
| -62.82% | $899.46M | |
| -30.28% | $810.71M | |
| -31.80% | $1.18B | |
| -69.05% | $1.30B | |
| -163.51% | $681.46M | |
| -50.20% | $847.53M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LENZ Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like LENZ Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is LENZ Therapeutics, Inc.'s ROE?
How is the ROE calculated for LENZ Therapeutics, Inc. (LENZ)?
What is the highest ROE for LENZ Therapeutics, Inc. (LENZ)?
What is the 3-year average ROE for LENZ Therapeutics, Inc. (LENZ)?
What is the 5-year average ROE for LENZ Therapeutics, Inc. (LENZ)?
How does the current ROE for LENZ Therapeutics, Inc. (LENZ) compare to its historical average?